Detection of leucine-rich alpha-2-glycoprotein 1-containing immunocomplexes in the plasma of lung cancer patients with epitope-specific mAbs.
暂无分享,去创建一个
[1] L. Dai,et al. Discovering Panel of Autoantibodies for Early Detection of Lung Cancer Based on Focused Protein Array , 2021, Frontiers in Immunology.
[2] Juan Zhou,et al. Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer , 2021, Frontiers in Oncology.
[3] Lai-Feng Wei,et al. A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer , 2021, Journal of Cancer.
[4] H. D. de Jonge,et al. Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues , 2021, Cancers.
[5] X. Qin,et al. Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules , 2020, Journal of Cancer Research and Clinical Oncology.
[6] R. Zhuang,et al. The diagnostic value of a seven‐autoantibody panel and a nomogram with a scoring table for predicting the risk of non–small‐cell lung cancer , 2020, Cancer science.
[7] Qingfeng Li,et al. LRG1 promotes keratinocyte migration and wound repair through regulation of HIF-1α stability. , 2020, The Journal of investigative dermatology.
[8] Yufeng Cheng,et al. The clinical prognostic value of LRG1 in esophageal squamous cell carcinoma. , 2019, Current cancer drug targets.
[9] Bin Yang,et al. Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review , 2019, Cell Death Discovery.
[10] V. D’Agati,et al. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β-Induced Angiogenesis. , 2019, Journal of the American Society of Nephrology : JASN.
[11] J. Pe’er,et al. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma. , 2018, Investigative ophthalmology & visual science.
[12] Takashi Mishima,et al. Leucine‐rich α‐2 glycoprotein promotes lung fibrosis by modulating TGF‐β signaling in fibroblasts , 2017, Physiological reports.
[13] H. Sugano,et al. Leucine-rich α2-glycoprotein overexpression in the brain contributes to memory impairment , 2017, Neurobiology of Aging.
[14] A. Pantuck,et al. Optimizing peptide epitope-based autoantibody detection in cancer patients. , 2017, American Journal of Clinical and Experimental Immunology.
[15] Y. Doki,et al. Overexpression of leucine‐rich α2‐glycoprotein‐1 is a prognostic marker and enhances tumor migration in gastric cancer , 2017, Cancer science.
[16] L. Dai,et al. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[17] Jin-liang Kong,et al. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis , 2017, PloS one.
[18] L. Dai,et al. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer , 2017, Oncotarget.
[19] Yan Shi,et al. Leucine-rich alpha-2-glycoprotein-1, relevant with microvessel density, is an independent survival prognostic factor for stage III colorectal cancer patients: a retrospective analysis , 2017, Oncotarget.
[20] J. Robertson,et al. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule‐Based Risk Models for Detection of Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] T. Hibi,et al. Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis , 2016, Journal of Crohn's & colitis.
[22] Sanjeeva Srivastava,et al. Protein microarray applications: Autoantibody detection and posttranslational modification , 2016, Proteomics.
[23] N. Kohno,et al. Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma , 2016, PloS one.
[24] Alan B Hollingsworth,et al. Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer , 2016, PloS one.
[25] Shamseldeen Y. Mahmoud,et al. S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer. , 2016, Translational Lung Cancer Research.
[26] M. Ziman,et al. Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients. , 2016, Autoimmunity reviews.
[27] G. Wallstrom,et al. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[28] T. Ohkawara,et al. Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth suppression in the Lewis lung carcinoma cell lines , 2015, Oncotarget.
[29] Peter D. Burbelo,et al. New autoantibody detection technologies yield novel insights into autoimmune disease , 2014, Current opinion in rheumatology.
[30] Yong-Beom Park,et al. Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Disease Activity Biomarker in Patients with Rheumatoid Arthritis , 2014, Journal of Korean medical science.
[31] J. Jett,et al. udit of the autoantibody test , EarlyCDT ®-Lung , in 1600 patients : n evaluation of its performance in routine clinical practice , 2014 .
[32] John Greenwood,et al. LRG1 promotes angiogenesis by modulating endothelial TGFß signalling , 2013, Nature.
[33] P. Boyle,et al. EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays , 2012, Tumor Biology.
[34] B. Karger,et al. Discovery of Lung Cancer Biomarkers by Profiling the Plasma Proteome with Monoclonal Antibody Libraries , 2011, Molecular & Cellular Proteomics.
[35] Yuan Zhang,et al. Proteomic identification of exosomal LRG1: A potential urinary biomarker for detecting NSCLC , 2011, Electrophoresis.
[36] J. Solassol,et al. Clinical Relevance of Autoantibody Detection in Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[37] P. Boyle,et al. Clinical validation of an autoantibody test for lung cancer , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[38] A. Skubitz,et al. Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients , 2010, Journal of ovarian research.
[39] C. Bokemeyer,et al. Autoantibodies against tumor-related antigens: incidence and biologic significance. , 2010, Human immunology.
[40] E. Gottlin,et al. Complement Factor H Autoantibodies Are Associated with Early Stage NSCLC , 2010, Clinical Cancer Research.
[41] J. Robertson,et al. Technical validation of an autoantibody test for lung cancer , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[42] Hwee Tong Tan,et al. Serum autoantibodies as biomarkers for early cancer detection , 2009, The FEBS journal.
[43] Kiyoshi Ikeda,et al. Up-regulation of the expression of leucine-rich α2-glycoprotein in hepatocytes by the mediators of acute-phase response , 2009, Biochemical and Biophysical Research Communications.
[44] L. Druhan,et al. LRG‐accelerated differentiation defines unique G‐CSFR signaling pathways downstream of PU.1 and C/EBPε that modulate neutrophil activation , 2008, Journal of leukocyte biology.
[45] H. Kato,et al. Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): Up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer , 2007, Journal of Chromatography B.
[46] A. Simpson,et al. Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.
[47] N. Tsuji,et al. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients. , 2005, Lung cancer.
[48] D. McNeel,et al. Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer , 2000, Breast Cancer Research and Treatment.
[49] N. Kohno,et al. Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer. , 2000, American journal of respiratory and critical care medicine.
[50] Yao-Tseng Chen,et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. , 1997, Proceedings of the National Academy of Sciences of the United States of America.